You were just on a panel and you said you have an aversion to making news. I'm going to try. Nonetheless, I think there are a lot of folks wondering about Brazil in particular.As soon as this test case for the section 301 tariffs statutory deadline is today. Anything that you can say about the process and where it stands and what we can expect, it's today. So our section 301 investigations, they are legal investigations.We have two sets of hearings. We do two sets of public comments. And we're focused on un ...

The world’s largest drugmaker is betting big on preventive medicines—and learning from big tech https://t.co/BhrrA44rzT ...

Boehringer Ingelheim’s top-selling drug lifted sales in the first half, as the German drugmaker gears up to file for U.S. approval of a new obesity medicine. https://t.co/tcakKniBYn ...

The launch of weight-loss pills is the hottest battle in pharma. So far, Eli Lilly is losing to rival Novo Nordisk. https://t.co/GbmAU1tQVv ...